ING Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-32,000
Closed -$461K 599
2023
Q4
$461K Sell
32,000
-96,184
-75% -$1.31M ﹤0.01% 511
2023
Q3
$2.23M Buy
128,184
+91,749
+252% +$1.91M 0.02% 360
2023
Q2
$758K Buy
36,435
+29,311
+411% +$637K 0.01% 450
2023
Q1
$168K Buy
+7,124
New +$191K ﹤0.01% 529
2022
Q3
Sell
-7,529
Closed -$254K 504
2022
Q2
$254K Buy
+7,529
New +$264K ﹤0.01% 522
2022
Q1
Sell
-33,093
Closed -$1.01M 585
2021
Q4
$1.01M Buy
33,093
+11,809
+55% +$385K 0.01% 565
2021
Q3
$698K Buy
21,284
+502
+2% +$16.1K 0.01% 554
2021
Q2
$629K Buy
+20,782
New +$684K 0.01% 507

Other funds holding OGN

ING Group's OGN Position: Q1 2024 in Review

ING Group sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 32,000 shares — an estimated $461K sold.

ING Group first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $2.23M in Q3 2023. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • ING Group reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • ING Group sold 32,000 Organon & Co shares in Q1 2024, an estimated $461K.
  • ING Group first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • ING Group's Organon & Co position peaked at $2.23M in Q3 2023.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on ING Group's 13F filing for Q1 2024, filed 10 May 2024.